Kouyos, Roger D.
,
Rusert, Peter
Kadelka, Claus
Huber, Michael
Marzel, Alex
Ebner, Hanna
Schanz, Merle
Liechti, Thomas
Friedrich, Nikolas
Braun, Dominique L.
Scherrer, Alexandra U.
Weber, Jacqueline
Uhr, Therese
Baumann, Nicolas S.
Leemann, Christine
Kuster, Herbert
Chave, Jean-Philippe
Cavassini, Matthias
Bernasconi, Enos
Hoffmann, Matthias
Calmy, Alexandra
Battegay, Manuel
Rauch, Andri
Yerly, Sabine
Aubert, Vincent
Klimkait, Thomas
Böni, Jürg
Metzner, Karin J.
Günthard, Huldrych F.
Trkola, Alexandra
Article History
Received: 12 February 2018
Accepted: 9 August 2018
First Online: 10 September 2018
Competing interests
: The University of Zurich filed a European patent application (EP18184854.0) that includes the full envelope sequences of patients T282 and R282 or components thereof for use as bNAb-inducing immunogens with R.D.K., P.R., H.F.G. and A.T. listed as inventors. All other authors declare no competing interests.
Free to read: This content has been made available to all.